Royalty Pharma plc (NASDAQ: RPRX) is 17.56% higher on its value in year-to-date trading and has touched a low of $24.05 and a high of $31.66 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RPRX stock was last observed hovering at around $29.49 in the last trading session, with the day’s gains setting it 0.5%.
Currently trading at $29.99, the stock is 16.42% and 14.91% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.82 million and changing 1.70% at the moment leaves the stock 9.73% off its SMA200. RPRX registered 4.20% gain for a year compared to 6-month loss of 12.03%. The firm has a 50-day simple moving average (SMA 50) of $26.0418 and a 200-day simple moving average (SMA200) of $27.3316.
The stock witnessed a 17.19% gain in the last 1 month and extending the period to 3 months gives it a 9.09%, and is 16.06% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.85% over the week and 2.31% over the month.
Royalty Pharma plc (RPRX) has around 89 employees, a market worth around $17.67B and $2.27B in sales. Current P/E ratio is 11.73 and Fwd P/E is 6.71. Profit margin for the company is 50.52%. Distance from 52-week low is 24.70% and -5.26% from its 52-week high. The company has generated returns on investments over the last 12 months (8.49%).
with sales reaching $622.43M over the same period.The EPS is expected to shrink by -11.80% this year, but quarterly earnings will post 12.66% year-over-year. Quarterly sales are estimated to grow 4.44% in year-over-year returns.
Royalty Pharma plc (RPRX) Top Institutional Holders
648.0 institutions hold shares in Royalty Pharma plc (RPRX), with institutional investors hold 84.02% of the company’s shares. The shares outstanding are 446.04M, and float is at 380.55M with Short Float at 4.35%. Institutions hold 72.96% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 44.13 million shares valued at $1.16 billion. The investor’s holdings represent 9.8375% of the RPRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 38.02 million shares valued at $1.0 billion to account for 8.4754 of the shares outstanding. The other top investors are FMR LLC which holds 27.89 million shares representing 6.2161% and valued at over $735.37 million, while BLACKROCK INC. holds 5.1307 of the shares totaling 23.02 million with a market value of $606.97 million.
Royalty Pharma plc (RPRX) Insider Activity
#####
